Cardiology

• In the Journals

• Center volume did not influence outcomes with TEVAR

• April 10, 2013
• Thoracic endovascular aortic repair can be safely performed at low- and high-volume hospitals regardless of teaching status, whereas open surgery should...More »

• Meeting News Coverage Video

• Cangrelor possibly has new place in clinical practice

• April 10, 2013
• SAN FRANCISCO — Jessica L. Mega, MD, from Brigham and Women’s Hospital, discuss results from the CHAMPION PHOENIX trial, noting that, with the...More »

• Discontinuation of HT may increase risk for hypertension

• April 10, 2013
• After the results of the Women’s Health Initiative more than a decade ago, many patients discontinued hormone therapy or estrogen therapy. New data...More »

• Discontinuation of HT may increase risk for hypertension

• Endocrine Today, May 2013
• After the results of the Women’s Health Initiative more than a decade ago, many patients discontinued hormone therapy or estrogen therapy. New data...More »

• Meeting News Coverage Video

• CHAMPION PHOENIX may have important clinical implications

• April 8, 2013
• SAN FRANCISCO — Cardiology Today’s Intervention Editorial Board member, Dean J. Kereiakes, MD, shares his thoughts on the CHAMPION...More »

• In the Journals

• ABO blood type increased risk for VTE

• April 8, 2013
• Those with ABO blood type are at a 20% greater risk for venous thromboembolism than the general population, according to results of a study conducted in...More »

• Prevalence of self-reported hypertension increased from 2005 to 2009

• Cardiology Today, May 2013
• From 2005 to 2009, the prevalence of self-reported hypertension among US adults increased from 25.8% to 28.3%. In addition, there was a concomitant...More »

• Walking, running produce similar improvements in heart health

• April 5, 2013
• Moderate-intensity walking and vigorous running appear to produce similar risk reductions for hypertension, hypercholesterolemia, diabetes and, possibly,...More »

• Meeting News Coverage Video

• More effective P2Y12 inhibitors beneficial for clopidogrel nonresponders

• April 4, 2013
• SAN FRANCISCO — Elad Asher, MD, interventional cardiology fellow at Harrington Heart & Vascular Institute, University Hospital Center in...More »

• In the Journals

• Platelet inhibition higher with ticagrelor for patients with diabetes

• April 1, 2013
• In a pharmacodynamic comparison of ticagrelor and prasugrel in patients with type 2 diabetes and ACS undergoing PCI, ticagrelor was associated with...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!